Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Aerie Pharmaceuticals (NQ: AERI ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Nov 18, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Aerie Pharmaceuticals < Previous 1 2 3 4 5 Next > Aerie Pharmaceuticals's Return On Capital Employed Overview November 25, 2022 Via Benzinga Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business November 22, 2022 From Alcon Inc. Investors Via Business Wire AiViva Reports That Their Promising New Treatment For Wet AMD Is Soon To Be Ready For Clinical Trials November 14, 2022 Visit https://www.startengine.com/aiviva to invest in AiViva’s StartEngine Campaign. Via Benzinga Aerie Pharmaceuticals Reports Third Quarter 2022 Financial Results November 03, 2022 From Aerie Pharmaceuticals, Inc. Via Business Wire AERIE PHARMACEUTICALS - INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. - AERI October 14, 2022 From Kahn Swick & Foti, LLC Via Business Wire Small-Cap Catalyst Pharma Is Among Market's Best Price Performers October 04, 2022 Small-cap biotech Catalyst Pharmaceuticals has been outperforming the broader market amid earnings and revenue acceleration. It joined the S&P 600 last month. Via MarketBeat Topics Stocks Exposures US Equities Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This Year September 19, 2022 The biotech run off a June bottom is great — until you realize you could've netted more. Via Investor's Business Daily Aerie Pharmaceuticals to Host Key Opinion Leader Event on Dry Eye Disease: Current Landscape, Unmet Needs, and Emerging Treatment Options September 13, 2022 From Aerie Pharmaceuticals, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2022 August 29, 2022 Upgrades Via Benzinga AERIE PHARMACEUTICALS - INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. - AERI August 24, 2022 From Kahn Swick & Foti, LLC Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2022 August 24, 2022 Via Benzinga Aerie Pharmaceuticals's Return On Capital Employed Overview August 24, 2022 According to data from Benzinga Pro, during Q2, Aerie Pharmaceuticals's (NASDAQ:AERI) reported sales totaled $33.31 million. Despite a 46.03% increase in earnings, the company posted a loss of $19.37... Via Benzinga AERI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Aerie Pharmaceuticals, Inc. Is Fair to Shareholders August 24, 2022 From Halper Sadeh LLP Via Business Wire Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday August 24, 2022 Gainers Via Benzinga Macy's, Palo Alto Networks And Other Big Gainers From Tuesday August 24, 2022 U.S. stocks closed mostly lower with the Dow Jones dropping more than 150 points on Tuesday. Here is the list of some big stocks moving higher in the previous session. Via Benzinga Alcon May Struggle To Meet 2023 Margin Targets With This Latest Acquisition, Says This Analyst August 23, 2022 Via Benzinga Dow Drops Over 100 Points; Aerie Pharmaceuticals Shares Spike Higher August 23, 2022 U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones dropping over 100 points on Tuesday. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session August 23, 2022 Via Benzinga Stocks Cut Lower As Dow Sheds Another Triple Digits August 23, 2022 Though most sectors are suffering today, especially real estate and healthcare, energy stocks are on the rise as oil prices make a big resurgence. Via Talk Markets Nasdaq Turns Lower; Crude Oil Rises Sharply August 23, 2022 U.S. stocks traded lower midway through trading, with the Nasdaq Composite turning negative on Tuesday. Via Benzinga Why Windtree Therapeutics Is Trading Higher By Over 60%, Here Are 61 Stocks Moving In Tuesday's Mid-Day Session August 23, 2022 Gainers Via Benzinga Why Is Ocugen (OCGN) Stock Climbing Higher Today? August 23, 2022 Ocugen (OCGN) stock is gaining on Tuesday after Mizuho Securities analysts initiated coverage of the medical company's shares. Via InvestorPlace Aerie Pharmaceuticals (NASDAQ: AERI) Enters into Agreement to be Acquired by Alcon (NYSE: ALC) for $770 Million August 23, 2022 Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) is engaged within the research, development and commercialization of ophthalmic therapies for the treatment of Via Spotlight Growth INTC Stock Alert: What to Know as Intel Co-Invests in Arizona Chip Factories August 23, 2022 Intel (INTC) stock is in the news today after the company announced its co-investment into Arizona semiconductor factories. Via InvestorPlace Why Is Aerie Pharmaceuticals (AERI) Stock Up 35% Today? August 23, 2022 Aerie Pharmaceuticals (AERI) stock is rising higher on Tuesday following news of a $770 million acquisition deal with Alcon (ALC). Via InvestorPlace US Stocks Mixed; Dow Falls 50 Points August 23, 2022 U.S. stocks traded mixed this morning, with the Dow Jones dropping around 50 points on Tuesday. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2022 August 23, 2022 Via Benzinga Blistering-Hot Biotech Shopping Spree Continues: Alcon To Buy Aerie For $770 Million August 23, 2022 The biopharma buying spree continued Tuesday with glaucoma drugs maker Aerie. Via Investor's Business Daily AMC Entertainment Price Target Cut By This Analyst, Plus DA Davidson Predicts $318 For Estée Lauder August 23, 2022 DA Davidson cut the price target for The Estée Lauder Companies Inc. (NYSE: EL) from $342 to $318. Estée Lauder shares fell 0.4% to $264.29 in pre-market trading. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session August 23, 2022 Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
